Our story
Science that serves life.
Biotronics AI was officially founded in November 2024, but the R&D behind our technologies began in 2021. During the pandemic, we came to believe that science and technology must serve life better — and to do that, they have to be transparent, reproducible, impactful, and most importantly, accessible for everyone.
With this mission, we are dedicated to advancing open-source technologies, with a primary focus on the life sciences and drug development, so that discovery stays open, shared, and accountable to the people it exists to help.
Collaborate with us
Democratizing science and contributing back to the community sit at the core of everything we build at Biotronics AI. If open, reproducible, and safety-first research resonates with you, join our newsletter for updates on releases, papers, and calls for collaboration — or reach out directly to explore working together.